KAP is a hybrid of pharmacology and psychotherapy, and the collaborative therapeutic container is where most trainings go thin. Co-presented by a therapist and a psychiatric prescriber who have delivered individual and group KAP together since 2024, this session centers the clinical work: the three-part KAP protocol (preparation, experiential, integration) and the therapist's role in each phase, the difference between psycholytic and psychedelic/transpersonal processes and the therapeutic stance each asks of the clinician, how KAP differs from medical-model ketamine therapy, and what intake, screening, and adverse-effect management look like inside a collaborative, cross-discipline model of care. The session closes with the Ohio landscape: current ethical and legal considerations for KAP practice, including anticipated guidance from the CSWMFT Board. After this training participants will be able to:
Describe the three elements of the KAP protocol (preparation, experiential session, integration) and the therapist's role in each
Compare psycholytic and psychedelic/transpersonal treatment processes and the therapeutic stance each requires
Explain the differences between medical-model ketamine therapy and KAP, including the advantages and limitations of each
Identify key intake and screening considerations for a client beginning KAP, including common adverse effects and their mitigation strategies
Describe the current Ohio ethical and regulatory landscape for KAP practice, including anticipated guidance from the CSWMFT Board
Completing Course Eval & Receiving Your CE Certificate
Course Eval & CE Certificate (20 Questions)
Fulfills requirements for 3 hours of CEs